Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Global breast milk study aims to unlock secrets of infant nutrition

NCT ID NCT05119166

Knowledge-focused Sponsor: University of Manitoba Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study collects and analyzes breast milk from 1000 mothers in Tanzania, Pakistan, Burkina Faso, and Canada. Researchers will measure nutrients, antibodies, and other components to understand how milk composition varies and affects infant growth and health. The goal is to create a shared database to answer key questions about maternal and infant nutrition.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this research could reveal how breast milk varies globally and how it influences infant nutrition and growth.
What could go wrong
This is an observational study, not a treatment trial. It will not directly test any therapy or cure, and results may not lead to immediate health changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2019

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

CHILD Study: observational study of healthy term infants from Canada, Multi-ethnic (\~70% Caucasian; 30% others: Asian, First Nations, Black, other) ELICIT Study: factorial RCT study design, cohorts from Haydom, Tanzania, predominantly of Black and East African descent VITAL Study: 3-arm RCT study design, cohorts from Karachi, Pakistan, predominantly of Asian descent MISAMEIII Study: 2x2 cross-over RCT study design, cohorts from Hounde District, Burkina Faso, predominantly of Black and West African descent

Ages

15 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * CHILD Study: Full term healthy infant; singleton pregnancy; English literary * ELICIT Study: Adult mothers, child \<14 days, lives within 25km of Haydom * VITAL Study: Lactating, biological mothers * MISAMEIII Study: Confirmed (pregnancy test/ultrasound) pregnant women 15-40 years old, informed consent, self, parents or husband (for minors; assent). Exclusion Criteria: * CHILD Study: IVF; congenital abnormality; preterm delivery * ELICIT Study: Multiple gestation, birth defects/neonatal illness, weight \<1.5g, no intention to breastfeed, will move from area within 18 months * VITAL Study: Use of any ointments or topical solutions immediately prior to sampling, non-consent * MISAMEIII Study: Peanut allergy, gestational age \<20weeks, women who will not deliver babies in or live in study area by delivery date.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infant growth are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Infant growth Infant nutrition Maternal health

Contacts and locations

Locations

  • Manitoba Interdisciplinary Lactation Centre (MILC)

    Winnipeg, Manitoba, R3E3P4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.